Your browser doesn't support javascript.
loading
Pharmacological Ascorbate Suppresses Growth of Gastric Cancer Cells with GLUT1 Overexpression and Enhances the Efficacy of Oxaliplatin Through Redox Modulation.
Lu, Yun-Xin; Wu, Qi-Nian; Chen, Dong-Liang; Chen, Le-Zong; Wang, Zi-Xian; Ren, Chao; Mo, Hai-Yu; Chen, Ya; Sheng, Hui; Wang, Ying-Nan; Wang, Yun; Lu, Jia-Huan; Wang, De-Shen; Zeng, Zhao-Lei; Wang, Feng; Wang, Feng-Hua; Li, Yu-Hong; Ju, Huai-Qiang; Xu, Rui-Hua.
Afiliação
  • Lu YX; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Wu QN; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • Chen DL; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Chen LZ; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • Wang ZX; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Ren C; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • Mo HY; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Chen Y; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • Sheng H; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Wang YN; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • Wang Y; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Lu JH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • Wang DS; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Zeng ZL; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Wang F; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Wang FH; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Li YH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
  • Ju HQ; Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, China.
  • Xu RH; Department of Medical Oncology, Sun Yat-sen University Cancer Center, Guangzhou, 510060, China.
Theranostics ; 8(5): 1312-1326, 2018.
Article em En | MEDLINE | ID: mdl-29507622
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Ascórbico / Neoplasias Gástricas / Transportador de Glucose Tipo 1 / Oxaliplatina Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Middle aged Idioma: En Revista: Theranostics Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Austrália
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Ascórbico / Neoplasias Gástricas / Transportador de Glucose Tipo 1 / Oxaliplatina Tipo de estudo: Prognostic_studies Limite: Animals / Female / Humans / Middle aged Idioma: En Revista: Theranostics Ano de publicação: 2018 Tipo de documento: Article País de afiliação: China País de publicação: Austrália